MIR2392

Across TCGA pan-cancer cohorts, MIR2392 RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated MIR2392 data layer.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher MIR2392 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR2392 expression acts as an unfavorable survival marker.

UCEC, STAD, and KIRC are the cancer types where MIR2392 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Tertile	All	0.734	0.927	.010	96	view →
STAD	DFS	Tertile	All	0.218	0.561	.003	54	view →
KIRC	DFS	Tertile	IV	0.127	0.619	.008	36	view →
PCPG	OS	Tertile	All	0.142	0.963	<.001	36	view →
BLCA	DFS	Tertile	II,III,IV	0.096	0.625	<.001	18	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

MIR2392–UCEC (OS)

Open the UCEC breakdown →